.
189 P. ; 25cm.

Place hold on Evaluation of angiopoietin 2 and liver type arginase serum levels in patients with liver cirrhosis and hepatocellular carcinoma /

.
137 P. : 25cm.

Place hold on Biomarkers assessment for detection of hepatocellular carcinoma /

.
117Leaves : 30cm.

Place hold on Analytical studies on human alpha - L - fucosidase as a new marker for early detection of hepatocellular carcinoma and comparison with AFP by ROC analysis /

.
142 P. : 25cm.

Place hold on Biochemical study of some parameters in patients with liver diseases /

.
157 P. : 25cm.

Place hold on Evaluation of serum chromogranin-A, Alpha-1-fucosidase, Nitric oxide and Glutathione Peroxidase markers in Patients with Hepatocellular Carcinoma /

.
151P. : 25cm.

Place hold on Evaluation of the clinical utility of alpha feto protein - L₃ in the diagnosis of hepatocelluler carcinoma /

.
138 P. : 25cm.

Place hold on Circulating alpha-feto protein-mRNA as a marker for hepatocellular carcinoma /

.
184 P. : 25cm.

Place hold on Hepatoma - specific AFP (H-S- AFP) in the diagnosis of hepatocellular carcinoma /

.
162P. : 25cm.

Place hold on Significance of angiopoietin - 2 as a serum marker for hepatocelluar carcinoma /

.
173P. : 25cm.

Place hold on Ultrasound and color doppler characteristics of hepato - celluar carcinoma (HCC) in relation to serum level of alpha fetoprotein (AFP) /

.
191P : 25cm.

Place hold on Correlation between CA 19 - 9 and alpha fetoprotein (AFP) in diagnosed cases of hepatocellular carcinoma /

.
305 P. ; 25cm.

Place hold on Serum levels of ace , angiotensin ii and ca19 - 9 in egyptian patients with liver cirrhosis and in hepatocellular carcinoma /

.
171P. : 25cm.

Place hold on Significance of serum chromogranin A in patients with liver cirrhosis and hepatocellular carcinoma /

.
105P. : 25Cm.

Place hold on Abruptio placentae /